跳至主要内容
临床试验/CTRI/2018/05/014151
CTRI/2018/05/014151已完成2 期

Comparative therapeutic evaluation of unani coded formulations with and without Munzij & Munshil Therapy in cases of Sinusitis (Iltehab-e-Tajaweef-e-Anaf)

Central Council for Research in Unani Medicine1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2008年1月10日最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
120
试验地点
1
主要终点
Safety evaluations:

研究概览

简要总结

Sinusitis is a clinical condition which is globally prevalent and affects large population in all age groups.

The treatment in conventional modern system of medicine mostly consists of antibiotics, anti histemenic and decongestants which does not cure all, necessitating surgical interventions in good no. of patients which too does not provide complete and irreversible relief. hence it is of paramount importance to search new and safe therapies for the effective management of this disease.

Ancient unani physicians have been treating different types of nazla including nazla-e-barid- muzmin. The symptomatology of which corresponds to sinusitis. Keeping this in view the present study has been planned and the trial drugs have proved safe and efficacious in the management of this disease.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Participant and Investigator Blinded

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with radiologically confirmed sinusitis Presence of any one of the signs and symptoms:
  • Nasal discharge
  • Nasal obstruction,
  • Deviated and hypertrophied nasal septum.

排除标准

  • patients with PAN sinusitis
  • Hepato renal, cardio pulmonary disorders
  • Pregnant and lactating women
  • those on oral contraceptives
  • those on active treatment from other systems of medicine.

结局指标

主要结局

Safety evaluations:

时间窗: Baseline, 15th days, 30th days, 45th days, 60th days, 90th days.

Efficacy evaluations:

时间窗: Baseline, 15th days, 30th days, 45th days, 60th days, 90th days.

Radiological clearance of sinuses.

时间窗: Baseline, 15th days, 30th days, 45th days, 60th days, 90th days.

2. improvement in the following signs and symptoms: Nasal discharge, sneezing, headache, nasal obstruction, malaise.

时间窗: Baseline, 15th days, 30th days, 45th days, 60th days, 90th days.

clinical laboratory tests: LFT, RFT, AE/ ADR reporting

时间窗: Baseline, 15th days, 30th days, 45th days, 60th days, 90th days.

次要结局

  • Safety measures pathological and biochemical investigations(Before and after treatment)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验